Promising Updated Phase II Data Presented at ASCO 2023 for Ivonescimab
First US Patient Treated in Ivonescimab Phase III Clinical Trial with the First Patient in Ivonescimab's Second Phase III Clinical Trial Planned for the Second Half of 2023
https://finance.yahoo.com/news/summit-therapeutics-reports-financial-results-110000590.html
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.